抗体媒介によるラッサウイルス中和の構造的基礎
Kathryn M Hastie1, Michelle A Zandonatti1, Lara M Kleinfelter2
1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
まとめ
ラッサウイルスのグリコタンパク質 (GPC) の構造は,抗体がウイルスを中和する方法を明らかにします. この発見は,ラッサ出血熱に対するワクチンの設計のためのテンプレートを提供します.
科学分野:
- ウイルス学
- 構造生物学
- 免疫学
背景:
- ラッサウイルスは重度の出血熱を引き起こし,西アフリカでは深刻な健康問題となっています.
- ウイルスのグリコタンパク質 (GPC) は,抗体を中和する主な標的である.
研究 の 目的:
- ラッサウイルスの結晶構造を,中和抗体との複合で決定する.
- 抗体媒介によるウイルス中和のメカニズムを解明する.
主な方法:
- 3. 2アングストロムの解像度でX線結晶撮影
- 抗体とGPCの相互作用と機能的抑制の生化学分析
主要な成果:
- 結晶構造は2つのモノマーを固定し,三重性GPCの基底に広く結合する抗体を明らかにします.
- 生化学的なデータは,ウイルスの侵入に必要な形状の変化を阻害することによって中和が起こることを示しています.
- この研究は,GPCサブユニット内のpHによる構造変化を明らかにします.
結論:
- 決定された構造は,アレナウイルスグリコプロテインのスパイクアセンブリの詳細な見方を提供します.
- この研究は効果的なラッサウイルスワクチンの開発に不可欠な模板を提供します.
- ラッサウイルスの脅威に対する戦略を策定するのに役立ちます.
さらに関連する動画
関連する概念動画
Antibody Actions
3.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.2K
Immune Response Against Viral Pathogens
2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
Cross-reactivity
33.3K
Overview
33.3K
Antibody Structure
66.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.3K
Antibody Structure and Classes
9.7K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.7K
Humoral Immune Responses
84.7K
Overview
84.7K


